The page is the record's research on the issuer — no analyst, no rating, no view. # Telomir Pharmaceuticals, Inc. (NASDAQ: TELO) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Telomir Pharmaceuticals, Inc., listed on NASDAQ under the ticker TELO. The ISIN is US87975F1049. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-FL. The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Florida. The segment is not on the record. The listing status is listed, not halted. ## The disclosure read The record holds 50 filings in the twelve months to 2026-11-08, across 38 filing days. The median gap between filing days is 6 days. The latest filing is dated 2026-11-06, two days before the record date, and its type is results. The exchange median is 6.0 days for cadence, 52 filings and 5.0 days of latency across 4359 issuers. The sector median is 6.0 days for cadence, 63.0 filings and 4.0 days of latency across 526 issuers. The issuer's latency of 2 days is below the exchange median of 5.0 days and below the sector median of 4.0 days. Its filings are 50, below the exchange median of 52 and below the sector median of 63.0. ## Auditor The auditor of record is SALBERG & COMPANY, P.A., located in Boca Raton, Florida. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting, or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer is sealed for the years 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001971532.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/TELO (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1971532/000149315226010625/form10-k.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/TELO (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/TELO · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp